Raab & Moskowitz Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.45M | Sell |
25,628
-154
| -0.6% | -$33.1K | 1.3% | 21 |
|
|
2026
Q1 | $5.61M | Sell |
25,782
-600
| -2% | -$133K | 1.25% | 24 |
|
|
2025
Q4 | $6.03M | Buy |
26,382
+338
| +1% | +$77K | 1.32% | 18 |
|
|
2025
Q3 | $6.03M | Sell |
26,044
-166
| -0.6% | -$33.8K | 1.35% | 20 |
|
|
2025
Q2 | $4.87M | Buy |
26,210
+122
| +0.5% | +$22.7K | 1.16% | 21 |
|
|
2025
Q1 | $5.47M | Sell |
26,088
-214
| -0.8% | -$41.6K | 1.37% | 19 |
|
|
2024
Q4 | $4.67M | Sell |
26,302
-212
| -0.8% | -$39K | 1.15% | 22 |
|
|
2024
Q3 | $5.24M | Buy |
26,514
+81
| +0.3% | +$15.1K | 1.33% | 21 |
|
|
2024
Q2 | $4.53M | Sell |
26,433
-196
| -0.7% | -$32.5K | 1.23% | 21 |
|
|
2024
Q1 | $4.85M | Sell |
26,629
-13
| -0% | -$2.24K | 1.36% | 19 |
|
|
2023
Q4 | $4.13M | Sell |
26,642
-323
| -1% | -$47.1K | 1.3% | 20 |
|
|
2023
Q3 | $4.02M | Sell |
26,965
-18
| -0.1% | -$2.64K | 1.42% | 21 |
|
|
2023
Q2 | $3.64M | Sell |
26,983
-467
| -2% | -$68.5K | 1.24% | 22 |
|
|
2023
Q1 | $4.37M | Sell |
27,450
-507
| -2% | -$77.5K | 1.6% | 16 |
|
|
2022
Q4 | $4.52M | Sell |
27,957
-71
| -0.3% | -$10.9K | 1.72% | 14 |
|
|
2022
Q3 | $3.76M | Sell |
28,028
-265
| -0.9% | -$38K | 1.58% | 17 |
|
|
2022
Q2 | $4.33M | Buy |
28,293
+152
| +0.5% | +$23.2K | 1.7% | 14 |
|
|
2022
Q1 | $4.56M | Buy |
28,141
+20
| +0.1% | +$2.9K | 1.56% | 15 |
|
|
2021
Q4 | $3.81M | Hold |
28,121
| – | – | 1.25% | 23 |
|
|
2021
Q3 | $3.03M | Sell |
28,121
-637
| -2% | -$72.8K | 1.1% | 27 |
|
|
2021
Q2 | $3.24M | Buy |
28,758
+502
| +2% | +$56.5K | 1.18% | 25 |
|
|
2021
Q1 | $3.06M | Buy |
28,256
+17,035
| +152% | +$1.82M | 1.19% | 25 |
|
|
2020
Q4 | $1.2M | Sell |
11,221
-300
| -3% | -$28.8K | 0.49% | 64 |
|
|
2020
Q3 | $1.01M | Sell |
11,521
-368
| -3% | -$34.6K | 0.47% | 63 |
|
|
2020
Q2 | $1.17M | Buy |
11,889
+117
| +1% | +$10.3K | 0.57% | 53 |
|
|
2020
Q1 | $896K | Buy |
11,772
+208
| +2% | +$17.7K | 0.49% | 65 |
|
|
2019
Q4 | $1.02M | Sell |
11,564
-232
| -2% | -$19.3K | 0.4% | 74 |
|
|
2019
Q3 | $893K | Sell |
11,796
-297
| -2% | -$20.4K | 0.39% | 77 |
|
|
2019
Q2 | $879K | Sell |
12,093
-170
| -1% | -$13.4K | 0.39% | 78 |
|
|
2019
Q1 | $988K | Sell |
12,263
-397
| -3% | -$32.5K | 0.45% | 72 |
|
|
2018
Q4 | $1.17M | Buy |
12,660
+97
| +0.8% | +$8.53K | 0.57% | 59 |
|
|
2018
Q3 | $1.19M | Buy |
12,563
+2,499
| +25% | +$237K | 0.49% | 62 |
|
|
2018
Q2 | $932K | Sell |
10,064
-127
| -1% | -$12.4K | 0.45% | 68 |
|
|
2018
Q1 | $964K | Buy |
10,191
+296
| +3% | +$32.5K | 0.47% | 63 |
|
|
2017
Q4 | $956K | Sell |
9,895
-358
| -3% | -$33.7K | 0.46% | 67 |
|
|
2017
Q3 | $925K | Sell |
10,253
-699
| -6% | -$53.2K | 0.45% | 70 |
|
|
2017
Q2 | $771K | Sell |
10,952
-332
| -3% | -$22.3K | 0.38% | 76 |
|
|
2017
Q1 | $735K | Buy |
11,284
+342
| +3% | +$21.5K | 0.38% | 77 |
|
|
2016
Q4 | $685K | Buy |
10,942
+16
| +0.1% | +$977 | 0.37% | 76 |
|
|
2016
Q3 | $689K | Sell |
10,926
-988
| -8% | -$64K | 0.39% | 77 |
|
|
2016
Q2 | $737K | Sell |
11,914
-252
| -2% | -$15.4K | 0.42% | 72 |
|
|
2016
Q1 | $694K | Buy |
12,166
+92
| +0.8% | +$5.13K | 0.41% | 71 |
|
|
2015
Q4 | $715K | Sell |
12,074
-111
| -0.9% | -$6.39K | 0.43% | 71 |
|
|
2015
Q3 | $662K | Sell |
12,185
-904
| -7% | -$58.8K | 0.43% | 70 |
|
|
2015
Q2 | $879K | Hold |
13,089
| – | – | 0.54% | 63 |
|
|
2015
Q1 | $766K | Sell |
13,089
-1,568
| -11% | -$94.7K | 0.46% | 70 |
|
|
2014
Q4 | $959K | Sell |
14,657
-26,270
| -64% | -$1.66M | 0.55% | 56 |
|
|
2014
Q3 | $2.36M | Sell |
40,927
-399
| -1% | -$22.2K | 1.15% | 24 |
|
|
2014
Q2 | $2.33M | Sell |
41,326
-230
| -0.6% | -$12.1K | 1.11% | 24 |
|
|
2014
Q1 | $1.64M | Sell |
41,556
-2,964
| -7% | -$150K | 0.91% | 33 |
|
|
2013
Q4 | $1.83M | Buy |
+44,520
| New | +$2.19M | 1.05% | 27 |
|
Other funds holding ABBV
Raab & Moskowitz Asset Management's ABBV Position: Q2 2026 in Review
Raab & Moskowitz Asset Management reduced its AbbVie (ABBV) stake by 0.6% in Q2 2026, selling an estimated $33.1K and leaving 25,628 shares worth $6.45M. The position accounts for 1.3% of the portfolio, ranked #21.
Raab & Moskowitz Asset Management first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Raab & Moskowitz Asset Management held 25,628 shares of AbbVie worth $6.45M as of Q2 2026.
- Raab & Moskowitz Asset Management sold 154 AbbVie shares in Q2 2026, an estimated $33.1K.
- AbbVie made up 1.3% of Raab & Moskowitz Asset Management's portfolio in Q2 2026, its #21 holding.
- Raab & Moskowitz Asset Management first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Raab & Moskowitz Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.